Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | F2 | P00734 | 2/20 | 0.62 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.62 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.62 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | CA5A | P35218 | 5/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL735400 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL31689627 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL3782036 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL20729441 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL12706679 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL23124424 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL467203 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL10000728 | 0.85 | KMT2A (0.70) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL5960692 | 0.85 | KMT2A (0.70) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL1362019 | 0.85 | KMT2A (0.70) | KMT2AALDH1A1F2PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365206-B2 | Stereoselective synthesis of benzimidazole sulfoxides | HETERO DRUGS LIMITED (IN) | 2008-04-29 | — | — | US | claimed |
| US-7176319-B2 | Process for substituted sulfoxides | HETERO DRUGS LIMITED (IN) | 2007-02-13 | — | — | US | claimed |
| US-20060166986-A1 | Novel stereoselective synthesis of benzimidazole sulfoxides | HETERO DRUGS LIMITED (IN) | 2006-07-27 | — | — | US | claimed |
| US-20060089386-A1 | Novel process for substituted sulfoxides | HETERO DRUGS LIMITED (IN) | 2006-04-27 | — | — | US | claimed |
| EP-3917907-B1 | MODULATORS OF POTASSIUM ION CHANNELS AND USES THEREOF | UNIV DEGLI STUDI DI SALERNO (IT) | 2025-05-21 | — | — | EP | disclosed |
| US-20250115687-A1 | PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, AND CATALYST FOR POLYMERIZAING OLEFINS | FORMOSA PLASTICS CORP USA (US) | 2025-04-10 | — | — | US | disclosed |
| EP-3191464-B1 | SYNTHESIS OF ISOFLAVANES AND INTERMEDIATES THEREOF | SYSTEM BIOLOGIE AG (CH) | 2019-11-06 | — | — | EP | disclosed |
| US-10030003-B2 | Synthesis of isoflavanes and intermediates thereof | SYSTEM BIOLOGIE AG (CH) | 2018-07-24 | — | — | US | disclosed |
| CN-108250008-A | 3,3,3`, 3`- tetramethyl -1,1`- spiro indan -6,6`- diol, derivatives chiral separation methods | 浙江大学 | 2018-07-06 | — | — | CN | disclosed |
| US-20170283389-A1 | Synthesis of Isoflavanes and Intermediates Thereof | SYSTEM BIOLOGIE AG (CH) | 2017-10-05 | — | — | US | disclosed |
| EP-3191464-A1 | SYNTHESIS OF ISOFLAVANES AND INTERMEDIATES THEREOF | System Biologie AG (CH) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016038061-A1 | SYNTHESIS OF ISOFLAVANES AND INTERMEDIATES THEREOF | SYSTEM BIOLOGIE AG (CH) | 2016-03-17 | — | — | WO | disclosed |
| US-5886044-A | IL-8 receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1999-03-23 | — | — | US | disclosed |
| EP-0860428-A2 | Sulphonamide derivatives | ELI LILLY AND COMPANY (US) | 1998-08-26 | — | — | EP | disclosed |
| WO-1998033496-A1 | SULPHONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1998-08-06 | — | — | WO | disclosed |
| US-5780480-A | THROMBOLYTIC AGENTS, ANTICOAGULANTS | MERCK & CO., INC. (US) | 1998-07-14 | — | — | US | disclosed |
| US-5780483-A | IL-8 receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1998-07-14 | — | — | US | disclosed |
| EP-0825164-A2 | Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides | ELI LILLY AND COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5175159-A | Prevention of premature labor | MERCK & CO., INC. (US) | 1992-12-29 | — | — | US | disclosed |
| EP-0421802-A2 | 3-substituted-1,4-benzodiazepines useful as oxytocin antagonists | MERCK & CO. INC. (US) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10030003-B2 | Synthesis of isoflavanes and intermediates thereof | CYP4B1, CYP51A1, CYP4A11 | KMT2A 1061/4885ALDH1A1 752/4885F2 117/4885 |
| US-20170283389-A1 | Synthesis of Isoflavanes and Intermediates Thereof | CYP4B1, CYP51A1, CYP4A11 | KMT2A 1061/4885ALDH1A1 752/4885F2 117/4885 |
| US-20060166986-A1 | Novel stereoselective synthesis of benzimidazole sulfoxides | CYP2S1, TPMT, SQOR | KMT2A 2740/4885ALDH1A1 245/4885F2 4320/4885 |
| US-20060089386-A1 | Novel process for substituted sulfoxides | STS, RPS6, RPS2 | KMT2A 4584/4885ALDH1A1 682/4885F2 4025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.